Perfil
Dr. Richard B.
Gayle is on the Board of Directors at Etubics Corp.
Dr. Gayle was previously employed as Senior Scientist by Immunex Corp.
He also served on the board at Sustainable Path Foundation.
He received his undergraduate degree from Rice University and a doctorate degree from the California Institute of Technology.
Antiguos cargos conocidos de Richard B. Gayle.
| Empresas | Cargo | Fin |
|---|---|---|
Immunex Corp.
 Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Director Técnico/Científico/I+D | 01/01/2002 |
| Sustainable Path Foundation | Fundador | - |
Etubics Corp.
 Etubics Corp. BiotechnologyHealth Technology Etubics Corp. develops commercial prophylactic vaccines and immunotherapy products. It offers proprietary immunization platform technology called the etubics platform that develops therapeutic vaccines for colon and breast cancers and preventative vaccines for H1N1 Influenza and HIV. The company was founded by Frank R. Jones in 2003 and is headquartered in Seattle, WA. | Director/Miembro de la Junta | - |
Formación de Richard B. Gayle.
| Rice University | Undergraduate Degree |
| California Institute of Technology | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Immunex Corp.
Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Health Technology |
Etubics Corp.
Etubics Corp. BiotechnologyHealth Technology Etubics Corp. develops commercial prophylactic vaccines and immunotherapy products. It offers proprietary immunization platform technology called the etubics platform that develops therapeutic vaccines for colon and breast cancers and preventative vaccines for H1N1 Influenza and HIV. The company was founded by Frank R. Jones in 2003 and is headquartered in Seattle, WA. | Health Technology |
| Sustainable Path Foundation |
- Bolsa de valores
- Insiders
- Richard B. Gayle
